Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
86 results:

  • 1. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
    Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
    Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
    Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
    Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. scRNA-seq of colorectal cancer shows regional immune atlas with the function of cd20
    Ji L; Fu G; Huang M; Kao X; Zhu J; Dai Z; Chen Y; Li H; Zhou J; Chu X; Lei Z
    Cancer Lett; 2024 Mar; 584():216664. PubMed ID: 38253219
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Role of High Mobility Group Box B-1 in the prognosis of colorectal cancer Based on the Changes in the Intestinal Mucosal Barrier.
    Zhao W; Chen A; Yuan N; Hao X; Wang C; Lu X; Song X; Zhang Z
    Technol Cancer Res Treat; 2024; 23():15330338231198972. PubMed ID: 38200714
    [No Abstract]    [Full Text] [Related]  

  • 5. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
    Edin S; Gylling B; Li X; Stenberg Å; Löfgren-Burström A; Zingmark C; van Guelpen B; Ljuslinder I; Ling A; Palmqvist R
    Br J Cancer; 2024 Jan; 130(1):143-150. PubMed ID: 38040818
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Deficiency of SR-B1 reduced the tumor load of colitis-induced or APC
    Chen Q; Wang L; Song H; Xing W; Shi J; Li Y; Wang Z; Chen J; Xie N; Zhao W
    Cancer Med; 2023 Oct; 12(19):19744-19757. PubMed ID: 37766594
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer.
    Lu Y; Zou R; Gu Q; Wang X; Zhang J; Ma R; Wang T; Wu J; Feng J; Zhang Y
    Cell Death Dis; 2023 Sep; 14(9):611. PubMed ID: 37716979
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in colorectal cancer and Invasive Breast cancer.
    Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
    Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Dihydropyrimidine Dehydrogenase (DPD) as a Bridge between the Immune Microenvironment of Colon cancers and 5-FU Resistance.
    Cui Z; He S; Wen F; Lu L; Xu L; Wu H; Wu S
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):80. PubMed ID: 37114540
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in colorectal cancer Liver Metastasis.
    Zhang D; Chen Z; Zhang L; Qian X; Huang X; Zheng Z; Pan W
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939250
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
    Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
    BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of potential biomarkers for colorectal cancer by clinical database analysis and Kaplan-Meier curves analysis.
    Li C; Gao Y; Lu C; Guo M
    Medicine (Baltimore); 2023 Feb; 102(6):e32877. PubMed ID: 36820595
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A prognostic score based on B cell and plasma cell densities compared to T cell densities in colorectal cancer.
    Karjalainen H; Sirniö P; Tuomisto A; Mäkinen MJ; Väyrynen JP
    Int J Colorectal Dis; 2023 Feb; 38(1):47. PubMed ID: 36800011
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): a novel prognostic factor in colorectal cancer.
    Xu Y; Zhu Y; Xia H; Wang Y; Li L; Wan H; Zhang S; Xu A; Wang L; Gong J; Zhang P
    BMC Cancer; 2023 Feb; 23(1):131. PubMed ID: 36755222
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer.
    Wang W; Zhang Y; Liu J; Jing H; Lu K; Wang L; Zhu T; Xu Y; Bu D; Cheng M; Liu J; Shen W; Yao J; Huang S
    World J Surg Oncol; 2023 Feb; 21(1):31. PubMed ID: 36726115
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
    Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical Features and Long-term prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.
    Hong SW; Ye BD; Cheon JH; Lee JH; Koo JS; Jang BI; Lee KM; Kim YS; Kim TO; Im JP; Song GA; Jung SA; Kim HS; Park DI; Kim HS; Huh KC; Kim YH; Cha JM; Seo GS; Choi CH; Song HJ; Baik GH; Kim JW; Shin SJ; Park YS; Lee CK; Lee J; Jung SH; Jung Y; Park SC; Joo YE; Jeen YT; Han DS; Yang SK; Kim HJ; Kim WH; Kim JS
    Gut Liver; 2022 Nov; 16(6):907-920. PubMed ID: 35321956
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Combined Positive Score for Programmed Death Ligand-1 Expression and Inflammatory Microenvironment in Gastrointestinal Stromal Tumors.
    Herlea V; Roșulescu A; Calotă VC; Croitoru V; Stoica Mustafa E; Vasilescu C; Alexandrescu S; Dumitrașcu T; Popescu I; Dima SO; Sajin M
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208498
    [No Abstract]    [Full Text] [Related]  

  • 19. Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon cancer-May Cold Tumors Simply Be Too Hot?
    Køstner AH; Nielsen PS; Georgsen JB; Parner ET; Nielsen MB; Kersten C; Steiniche T
    Front Immunol; 2021; 12():716342. PubMed ID: 34531864
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
    Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
    BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.